Advancing Rare-Cell Enrichment from Whole Blood
VitraCell is developing label-free microfluidic workflows to separate, collect, identify, and purify rare circulating cells
VitraCell is developing label-free microfluidic workflows to separate, collect, identify, and purify rare circulating cells
Rare circulating cells can provide valuable insight into tumor biology, disease progression, and future downstream analysis. However, isolating viable rare cells from whole blood remains technically difficult because target cells are vastly outnumbered by red blood cells, platelets, and leukocytes.
VitraCell is focused on solving this front-end sample-processing problem though a staged workflow that combines physical pre-enrichment with dielectrophoretic purification.
VitraCell's development program is centered on a two-stage rare-cell enrichment workflow:
VitraCell is currently preparing a Phase 1 grant-supported development program focused on technical feasibility. The initial work will evaluate recovery, viability, background-cell depletion, throughput, and reproducibility using both spiked whole blood samples followed by limited feasibility testing with oncology whole-blood specimens though appropriate collaboration and approvals.
This work is for research and development purposes only and is not intended for clinical diagnosis or treatment decision-making at this stage.
We are interested in speaking with oncology practices, academic investigators, translational research groups, and biomarker development partners interested in rare-cell isolation, sample-processing feasibility, and future liquid biopsy workflows.
We know that our clients have unique needs. Send us a message, and we will get back to you soon.
VitraCell Lexington, South Carolina Gregory Moore, Founder Gregory.Moore@VitraCell.io
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.